You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

8 Results
Guidelines and Advice
Regimen
Cancer Type:
Skin, 
Basal Cell
Intent: Palliative
Apr 2021
Cancer facts
Guidelines and Advice
Jun 2021
Guidelines and Advice
Drug
Other Name(s): Sylvant®
Mar 2025
Regimen
Cancer Type:
Hematologic, 
Rare Diseases
Intent: Palliative
Funding:
New Drug Funding Program
    Siltuximab - Multicentric Castleman’s Disease (MCD)
Mar 2025